Eltroxin 75 mcg (Thyroxine Sodium) angispan-tr-6-5 refer to the FDA’s drug

refer to the FDA’s drug label guidance FDA and the National Institutes of Health (NIH) clinical resources NIH

Explore the uses

Unlike some other NSAIDs

A: Clinical improvement in seizure control may be observed within 1‑2 weeks of consistent dosing

Eltroxin 75 mcg (Thyroxine Sodium) angispan-tr-6-5 refer to the FDA’s drugEltroxin 75 mcg (Thyroxine Sodium) Product Overview Eltroxin 75 mcg is a prescription medication that contains thyroxine sodium, a synthetic form of the thyroid hormone thyroxine (T4). It is manufactured by GlaxoSmithKline Pharmaceuticals Ltd and is primarily indicated for the treatment of hypothyroidism, a condition characterized by insufficient production of thyroid hormone by the thyroid gland. The medication is supplied in two packaging options: a